FIT Screening Cuts Risk of Death From Colorectal Cancer
By Lori Solomon HealthDay Reporter
TUESDAY, July 23, 2024 -- Screening with fecal immunochemical tests (FITs) lowers the risk of dying from colorectal cancer (CRC), according to a study published online July 19 in JAMA Network Open.
Chyke A. Doubeni, M.D., from The Ohio State University College of Medicine in Columbus, and colleagues evaluated whether FIT screening is associated with a lower risk of dying from CRC overall, as well as by cancer location and demographic group. Analysis included 1,103 people (aged 52 to 85 years) who died from colorectal adenocarcinoma between 2011 and 2017 (cases) and 9,608 controls matched (1:8) based on age, sex, health-plan membership duration, and geographic area.
The researchers found that completing one or more FIT screening was associated with a lower risk of death from CRC (adjusted odds ratio [aOR], 0.67) and lower risk in the left colon and rectum (aOR, 0.58). For right colon cancers, there was no significant association observed with FIT screening. The difference in the estimates between the right colon and left colon or rectum was statistically significant. The association between FIT screening and lower CRC mortality risk was seen across races (non-Hispanic Asian: aOR, 0.37; non-Hispanic Black: aOR, 0.58; non-Hispanic White: aOR, 0.70).
"This study provides U.S. community-based evidence that suggests FIT screening lowers the risk of dying from colorectal cancer and supports the strategy of population-based screening using FIT," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted July 2024
Read this next
Few With Abnormal Protein Dipstick Results Have Albuminuria Testing
MONDAY, Sept. 30, 2024 -- Few patients with abnormal protein dipstick results have follow-up albuminuria quantification, according to a research letter published online Oct. 1 in...
No Infections Seen After Transperineal Biopsy for Prostate Cancer
MONDAY, Sept. 30, 2024 -- For patients with suspicion for prostate cancer, transperineal biopsy has similar cancer detection rates as transrectal biopsy but a significantly lower...
Guideline Developed for Opioid Prescribing in Children With Acute Pain
MONDAY, Sept. 30, 2024 -- In a clinical practice guideline issued by the American Academy of Pediatrics and published online Sept. 30 in Pediatrics, recommendations are presented...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.